 |
|
Calendar of Events
March 2005 Events
Thursday, March 10th, 2005
Annual International Networking Evening & Business Forum |
| Topic: | New Global Frontiers:
The Emerging Markets of Asia, the Expanded EU and Beyond |
| Description: | Join us for the premier international event of the year the 11th Annual International Networking Evening and Business Forum! This event regularly attracts hundreds of companies involved in international business. The evening will feature informative seminars on global trade and an international resource center with more than 20 international trade associations and organizations representing over 5,000 New England companies. Come and meet people interested in world trade while learning about the resources available to help your company's international business! |
| Speakers: | 3:00 p.m. - 4:00 p.m.
The Global Economic Outlook:
Implications for International Business in the Year Ahead
Despite signs of an economic recovery, many companies are still
uncertain about the future of overseas markets. Which markets
offer stability? Which markets offer growth and opportunity?
Which markets aren't worth the risk? What is the impact of the
weakened dollar on trade and the dollars forecast for the future?
Get answers to these questions and many more from one of the
area's leading economists.
Christopher Probyn, Chief International Economist State
Street Corporation
4:30 p.m. 6:30 p.m.
New Global Frontiers: Business Opportunities in Emerging Markets of
the World
Many of the world's emerging markets also represent the fastest-growing
export markets for U.S. firms. For example, 2004 growth in U.S. exports to
China, Brazil and India was more than double the nation's export growth
overall. Also so-called "traditional" export markets like the European Union
expanded last year to include ten additional member states with future plans
for four more. U.S. companies that don't pursue these emerging markets
now may find themselves left behind in the future.
Oscar Escartin, Senior Partner C.O.P.E. International (Latin America)
Joseph Preston, VP International New Balance Athletic Shoe (Asia)
John Rankin, HM Consul General British Consulate General (EU Expansion)
Tomye Tierney, Vice President & General Manager, Emerging Markets
Genzyme Corporation (Pioneering Emerging Markets)
|
| Location: | Offices of Holland & Knight LLP [map]
10 St. James Avenue
11th Floor, Boston |
| Time: | 2:30 p.m. - Registration
3:00 p.m. 6:30 p.m. - Business Forum Seminars
6:30 p.m. 8:00 p.m. - Networking Reception |
| Fee: | $65 - Business Forum Seminars & Networking Reception
$35 - Networking Reception Only |
| RSVP: | Pre-registration is required by March 4, 2005.
Questions can be directed to GABC via email or call us at (617) 437-6588.
|
Thursday, March 31st, 2005
Presentation and Discussion |
| Topic: | "The Dark Side of Biotechnology" |
| Description: | Current advances in biotechnology and human genetics promise to lead to major changes in healthcare, but they also
raise the specter of possible malevolent uses. As a result of these changes we are at a key stage in human evolution,
and the different ways this is likely to be viewed in Eastern and Western cultures could significantly destabilize society.
Dr. Charles Cantor is Chief Scientific Officer and Member, Board of Directors, at SEQUENOM, Inc., a leader in studying genetic differences among people. He is founder in 2002 and member, Board of Directors, of SelectX Pharmaceuticals, a drug discovery company based in the Boston area. He is also the director of the Center for Advanced Biotechnology at Boston University, and professor of Biomedical Engineering.
Dr. Cantor has held positions at Columbia University and University of California at Berkeley, and was also director of the Human Genome Center of the Department of Energy at Lawrence Berkeley Laboratory. He has published more
than 360 peer-reviewed articles, has been granted more than 60 patents, and co-authored a three-volume textbook on Biophysical Chemistry and the first textbook on Genomics: The Science and Technology of the Human Genome
Project.
He sits on the advisory boards of more than a dozen international companies, is a member of a several government advisory boards, and is a member of the National Academy of Sciences. |
| Speaker: | Dr. Charles R. Cantor |
| Location: | Goethe-Institut Boston [map]
170 Beacon Street, Boston
(Parking is available in the Boston Common Garage) |
| Time: | 5:30 p.m. to 6:00 p.m. - Registration and Cocktails
6:00 p.m. to 7:30 p.m. - Presentation |
| Fee: | $20 - Members
$30 - Non-Members |
| RSVP: | Pre-registration is required by March 29, 2005.
Questions can be directed to GABC via email or call us at (617) 437-6588.
|
|
